Genmab A/S Files 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Mar 24, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
Related Tickers: GMAB
TL;DR
Genmab filed a 6-K on 3/24/25, incorporating into its S-8 filings. Standard update.
AI Summary
Genmab A/S filed a Form 6-K on March 24, 2025, to report information for the month of March 2025. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing serves as an update and is incorporated into existing registration statements, indicating ongoing corporate actions and disclosures relevant to investors holding or considering Genmab securities.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates previous information into registration statements, with no new material financial or operational events disclosed.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the filing date of this report?
This report was filed on March 24, 2025.
What is the primary purpose of this filing regarding other Genmab filings?
This report is deemed to be incorporated by reference into Genmab A/S's registration statements on Form S-8.
Which specific Form S-8 registration statements does this 6-K filing incorporate into?
This filing incorporates into Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876).
What is the principal executive office address of Genmab A/S?
The principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 24, 2025 regarding GENMAB A/S (GNMSF).